Literature DB >> 20811931

Real-time UV imaging of nicotine release from transdermal patch.

Jesper Østergaard1, Emil Meng-Lund, Susan Weng Larsen, Claus Larsen, Karsten Petersson, James Lenke, Henrik Jensen.   

Abstract

PURPOSE: This study was conducted to characterize UV imaging as a platform for performing in vitro release studies using Nicorette® nicotine patches as a model drug delivery system.
METHODS: The rate of nicotine release from 2 mm diameter patch samples (Nicorette®) into 0.067 M phosphate buffer, pH 7.40, was studied by UV imaging (Actipix SDI300 dissolution imaging system) at 254 nm. The release rates were compared to those obtained using the paddle-over-disk method.
RESULTS: Calibration curves were successfully established which allowed temporally and spatially resolved quantification of nicotine. Release profiles obtained from UV imaging were in qualitative agreement with results from the paddle-over-disk release method.
CONCLUSION: Visualization as well as quantification of nicotine concentration gradients was achieved by UV imaging in real time. UV imaging has the potential to become an important technology platform for conducting in vitro drug release studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20811931     DOI: 10.1007/s11095-010-0257-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets.

Authors:  Sevgi Takka; Adel Sakr; Arthur Goldberg
Journal:  J Control Release       Date:  2003-02-14       Impact factor: 9.776

2.  Analysis of data on the medicament release from ointments.

Authors:  W I HIGUCHI
Journal:  J Pharm Sci       Date:  1962-08       Impact factor: 3.534

Review 3.  Benchtop-NMR and MRI--a new analytical tool in drug delivery research.

Authors:  Hendrik Metz; Karsten Mäder
Journal:  Int J Pharm       Date:  2008-09-26       Impact factor: 5.875

4.  Microstructural analysis of porous composite materials: dynamic imaging of drug dissolution and diffusion through porous matrices.

Authors:  Paul M Young; Kathy Nguyen; Allan S Jones; Daniela Traini
Journal:  AAPS J       Date:  2008-11-14       Impact factor: 4.009

5.  Population in vitro-in vivo correlation model for pramipexole slow-release oral formulations.

Authors:  Elena Soto; Sebastian Haertter; Michael Koenen-Bergmann; Alexander Staab; Iñaki F Trocóniz
Journal:  Pharm Res       Date:  2009-12-29       Impact factor: 4.200

6.  Hydrodynamic and species transfer simulations in the USP 4 dissolution apparatus: considerations for dissolution in a low velocity pulsing flow.

Authors:  Deirdre M D'Arcy; Bo Liu; Geoff Bradley; Anne Marie Healy; Owen I Corrigan
Journal:  Pharm Res       Date:  2009-12-10       Impact factor: 4.200

Review 7.  In-vitro tomography and non-destructive imaging at depth of pharmaceutical solid dosage forms.

Authors:  J Axel Zeitler; Lynn F Gladden
Journal:  Eur J Pharm Biopharm       Date:  2008-08-22       Impact factor: 5.571

8.  Simultaneous evaluation of ligand binding properties and protein size by electrophoresis and Taylor dispersion in capillaries.

Authors:  Jesper Østergaard; Henrik Jensen
Journal:  Anal Chem       Date:  2009-10-15       Impact factor: 6.986

9.  Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a Level A in vitro-in vivo correlation (IVIVC).

Authors:  Sandeep Dutta; Yihong Qiu; Emil Samara; Guoliang Cao; G Richard Granneman
Journal:  J Pharm Sci       Date:  2005-09       Impact factor: 3.534

10.  FTIR imaging for the characterization of controlled-release drug delivery applications.

Authors:  Denise Wade Rafferty; Jack L Koenig
Journal:  J Control Release       Date:  2002-09-18       Impact factor: 9.776

View more
  9 in total

Review 1.  Application of UV Imaging in Formulation Development.

Authors:  Yu Sun; Jesper Østergaard
Journal:  Pharm Res       Date:  2016-10-20       Impact factor: 4.200

2.  A new approach to dissolution testing by UV imaging and finite element simulations.

Authors:  Johan P Boetker; Jukka Rantanen; Thomas Rades; Anette Müllertz; Jesper Ostergaard; Henrik Jensen
Journal:  Pharm Res       Date:  2013-01-11       Impact factor: 4.200

3.  Attenuated total reflection-Fourier transform infrared spectroscopic imaging of pharmaceuticals in microfluidic devices.

Authors:  Andrew V Ewing; Graham S Clarke; Sergei G Kazarian
Journal:  Biomicrofluidics       Date:  2016-04-20       Impact factor: 2.800

Review 4.  A Review of Disintegration Mechanisms and Measurement Techniques.

Authors:  Daniel Markl; J Axel Zeitler
Journal:  Pharm Res       Date:  2017-03-01       Impact factor: 4.200

5.  Fenofibrate Nanocrystals Embedded in Oral Strip-Films for Bioavailability Enhancement.

Authors:  Bhavesh D Kevadiya; Manish Barvaliya; Lu Zhang; Ashish Anovadiya; Harshad Brahmbhatt; Parimal Paul; Chandrabhanu Tripathi
Journal:  Bioengineering (Basel)       Date:  2018-02-13

6.  Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation.

Authors:  Chiau Ming Long; Kin Tang; Hitesh Chokshi; Nikoletta Fotaki
Journal:  AAPS PharmSciTech       Date:  2019-02-13       Impact factor: 3.246

7.  Methodological Considerations in Development of UV Imaging for Characterization of Intra-Tumoral Injectables Using cAMP as a Model Substance.

Authors:  Frederik Bock; Johan Peter Bøtker; Susan Weng Larsen; Xujin Lu; Jesper Østergaard
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

8.  Influence of sodium lauryl sulfate and tween 80 on carbamazepine-nicotinamide cocrystal solubility and dissolution behaviour.

Authors:  Mingzhong Li; Ning Qiao; Ke Wang
Journal:  Pharmaceutics       Date:  2013-10-11       Impact factor: 6.321

9.  Monitoring of Antimicrobial Drug Chloramphenicol Release from Electrospun Nano- and Microfiber Mats Using UV Imaging and Bacterial Bioreporters.

Authors:  Liis Preem; Frederik Bock; Mariliis Hinnu; Marta Putrinš; Kadi Sagor; Tanel Tenson; Andres Meos; Jesper Østergaard; Karin Kogermann
Journal:  Pharmaceutics       Date:  2019-09-19       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.